Literature DB >> 16503651

Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy.

Juliane Penner1, Lars R Mantey, Sharona Elgavish, Darius Ghaderi, Sebahattin Cirak, Markus Berger, Sabine Krause, Lothar Lucka, Thomas Voit, Stella Mitrani-Rosenbaum, Stephan Hinderlich.   

Abstract

Hereditary inclusion body myopathy (HIBM), a neuromuscular disorder, is caused by mutations in UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), the key enzyme of sialic acid biosynthesis. To date, more than 40 different mutations in the GNE gene have been reported to cause the disease. Ten of them, representing mutations in both functional domains of GNE, were recombinantly expressed in insect cells (Sf9). Each of the mutants that was analyzed displayed a reduction in the two known GNE activities, thus revealing that mutations may also influence the function of the domain not harboring them. The extent of reduction strongly differs among the point mutants, ranging from only 20% reduction found for A631T and A631V to almost 80% reduction of at least one activity in D378Y and N519S mutants and more than 80% reduction of both activities of G576E, underlined by structural changes of N519S and G576E, as observed in CD spectroscopy and gel filtration analysis, respectively. We therefore generated models of the three-dimensional structures of the epimerase and the kinase domains of GNE, based on Escherichia coli UDP-N-acetylglucosamine 2-epimerase and glucokinase, respectively, and determined the localization of the HIBM mutations within these proteins. Whereas in the kinase domain most of the mutations are localized inside the enzyme, mutations in the epimerase domain are mostly located at the protein surface. Otherwise, the different mutations result in different enzymatic activities but not in different disease phenotypes and, therefore, do not suggest a direct role of the enzymatic function of GNE in the disease mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503651     DOI: 10.1021/bi0522504

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Crystal structures of N-acetylmannosamine kinase provide insights into enzyme activity and inhibition.

Authors:  Jacobo Martinez; Long Duc Nguyen; Stephan Hinderlich; Reinhold Zimmer; Eva Tauberger; Werner Reutter; Wolfram Saenger; Hua Fan; Sébastien Moniot
Journal:  J Biol Chem       Date:  2012-02-16       Impact factor: 5.157

Review 2.  Mutation update for GNE gene variants associated with GNE myopathy.

Authors:  Frank V Celeste; Thierry Vilboux; Carla Ciccone; John Karl de Dios; May Christine V Malicdan; Petcharat Leoyklang; John C McKew; William A Gahl; Nuria Carrillo-Carrasco; Marjan Huizing
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

3.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 4.  Sialic acids in human health and disease.

Authors:  Ajit Varki
Journal:  Trends Mol Med       Date:  2008-07-06       Impact factor: 11.951

5.  Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in β1-integrin-mediated cell adhesion.

Authors:  Sonam Grover; Ranjana Arya
Journal:  Mol Neurobiol       Date:  2014-01-29       Impact factor: 5.590

6.  Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria.

Authors:  Natalya Kurochkina; Tal Yardeni; Marjan Huizing
Journal:  Glycobiology       Date:  2009-11-16       Impact factor: 4.313

Review 7.  Perspectives on distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy: contributions from an animal model. Lack of sialic acid, a central determinant in sugar chains, causes myopathy?

Authors:  M C V Malicdan; S Noguchi; I Nishino
Journal:  Acta Myol       Date:  2007-12

8.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08

9.  Crystal structure of the N-acetylmannosamine kinase domain of GNE.

Authors:  Yufeng Tong; Wolfram Tempel; Lyudmila Nedyalkova; Farrell Mackenzie; Hee-Won Park
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

10.  Hereditary Inclusion Body Myopathy (HIBM2).

Authors:  Chris M Jay; Nick Levonyak; Gregory Nemunaitis; Phillip B Maples; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.